These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 212033)

  • 1. Binding of [14C]tuberactinomycin O, an antibiotic closely related to viomycin, to the bacterial ribosome.
    Misumi M; Tanaka N; Shiba T
    Biochem Biophys Res Commun; 1978 Jun; 82(3):971-6. PubMed ID: 212033
    [No Abstract]   [Full Text] [Related]  

  • 2. tRNA binding to programmed ribosomes increases the ribosomal affinity for tuberactinomycin O.
    Yamada T; Teshima T; Shiba T; Nierhaus KH
    FEBS Lett; 1985 Jan; 179(1):37-40. PubMed ID: 2981179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of [14C]tuberactinomycin O to ribosomes from Mycobacterium smegmatis.
    Yamada T; Teshima T; Shiba T
    J Antibiot (Tokyo); 1985 Feb; 38(2):266-9. PubMed ID: 2987173
    [No Abstract]   [Full Text] [Related]  

  • 4. The translocation inhibitor tuberactinomycin binds to nucleic acids and blocks the in vitro assembly of 50S subunits.
    Yamada T; Teshima T; Shiba T; Nierhaus KH
    Nucleic Acids Res; 1980 Dec; 8(23):5767-77. PubMed ID: 6258151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ribosomes in the sensitivity of mycobacteria to tuberactinomycin.
    Yamada T
    Microbiol Immunol; 1987; 31(2):179-81. PubMed ID: 3037284
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of viomycin on dihydrostreptomycin binding to bacterial ribosomes.
    Masuda K; Yamada T
    Biochim Biophys Acta; 1976 Jul; 435(4):333-9. PubMed ID: 60132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
    Yamada T; Mizuguchi Y; Suga K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
    [No Abstract]   [Full Text] [Related]  

  • 8. Deciphering tuberactinomycin biosynthesis: isolation, sequencing, and annotation of the viomycin biosynthetic gene cluster.
    Thomas MG; Chan YA; Ozanick SG
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2823-30. PubMed ID: 12936980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of a viomycin-binding RNA pseudoknot.
    Wallis MG; Streicher B; Wank H; von Ahsen U; Clodi E; Wallace ST; Famulok M; Schroeder R
    Chem Biol; 1997 May; 4(5):357-66. PubMed ID: 9195872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.
    Akbergenov R; Shcherbakov D; Matt T; Duscha S; Meyer M; Wilson DN; Böttger EC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4712-7. PubMed ID: 21768509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome.
    Stanley RE; Blaha G; Grodzicki RL; Strickler MD; Steitz TA
    Nat Struct Mol Biol; 2010 Mar; 17(3):289-93. PubMed ID: 20154709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of viomycin inhibition of peptide elongation in bacteria.
    Holm M; Borg A; Ehrenberg M; Sanyal S
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):978-83. PubMed ID: 26755601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basic studies on viomycin and tuberactinomycin (author's transl)].
    Aoyagi T; Kawai T; Yamada Y; Fujino T; Kaneko K
    Kekkaku; 1975 Oct; 50(10):295-301. PubMed ID: 175205
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
    Tsukamura M; Mizuno S
    J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of di-beta-lysyl-capreomycin IIA and palmitoyl tuberactinamine N against drug-resistant mutants with altered ribosomes.
    Yamada T; Teshima T; Shiba T
    Antimicrob Agents Chemother; 1981 Dec; 20(6):834-6. PubMed ID: 6173016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of [14C]erythromycin to Escherichia coli ribosomes.
    Pestka S
    Antimicrob Agents Chemother; 1974 Oct; 6(4):474-8. PubMed ID: 4157348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic antibiotic resistance mutations associated with ribosomes and ribosomal subunits in Mycobacterium smegmatis.
    Yamada T; Masuda K; Shoji K; Hori M
    Antimicrob Agents Chemother; 1974 Jul; 6(1):46-53. PubMed ID: 15828170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical studies on tuberactinomycin. VIII. Isolation of tuberactinamine N, the cyclic peptide moiety of tuberactinomycin N, and conversion of tuberactinomycin N to O.
    Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1975 Apr; 28(4):292-7. PubMed ID: 808523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of Neurospora VS ribozyme cleavage by tuberactinomycin antibiotics.
    Olive JE; De Abreu DM; Rastogi T; Andersen AA; Mittermaier AK; Beattie TL; Collins RA
    EMBO J; 1995 Jul; 14(13):3247-51. PubMed ID: 7621836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies in vitro on the antituberculous activities of tuberactinomycin (TUM) and tuberactinomycin-N (TUM-N) (author's transl)].
    Maekawa N; Ikeda N; Oda Y; Uratsuji Y; Inagake H
    Kekkaku; 1977 May; 52(5):211-8. PubMed ID: 407391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.